NCT06302751 A Mobile Application to Improve Postoperative Outcomes in Colorectal Cancer
| NCT ID | NCT06302751 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istituto Clinico Humanitas |
| Condition | Colorectal Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 600 participants |
| Start Date | 2024-02-26 |
| Primary Completion | 2026-02-26 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 600 participants in total. It began in 2024-02-26 with a primary completion date of 2026-02-26.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The unplanned readmission rate after colorectal cancer surgery is still high, despite the implementation of enhanced recovery programs. The use of a mobile-based application for perioperative remote monitoring may improve the postoperative outcomes and reduce the unplanned postoperative readmissions.
Eligibility Criteria
Inclusion Criteria: * Patients aged more than 18 years old. * Patients scheduled for elective curative colorectal resection, including right (or extended) colectomy, left colectomy, rectal resection (with or without ileostomy), total colectomy, recanalization, or multiple colon resection. * Patients willing to comply with the study procedures. * Proficient understanding of the Italian language Exclusion Criteria: * Any condition that, in the opinion of the investigator, may interfere with the study procedures. * Patients scheduled for palliative surgery. * Patients with a planned elective intervention requiring urgent or emergent surgery will be withdrawn from the study. * Pregnant or breastfeeding women. * Inability to comply with the study procedures.
Contact & Investigator
Caterina Foppa, MD, PhD
PRINCIPAL INVESTIGATOR
Humanitas Research Hospital IRCCS, Rozzano-Milan
Frequently Asked Questions
Who can join the NCT06302751 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Colorectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06302751 currently recruiting?
Yes, NCT06302751 is actively recruiting participants. Contact the research team at colorapp@humanitas.it for enrollment information.
Where is the NCT06302751 trial being conducted?
This trial is being conducted at Rozzano, Italy.
Who is sponsoring the NCT06302751 clinical trial?
NCT06302751 is sponsored by Istituto Clinico Humanitas. The principal investigator is Caterina Foppa, MD, PhD at Humanitas Research Hospital IRCCS, Rozzano-Milan. The trial plans to enroll 600 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.